These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15115616)

  • 1. Binding activity of H-Ras is necessary for in vivo inhibition of ASK1 activity.
    Du J; Cai SH; Shi Z; Nagase F
    Cell Res; 2004 Apr; 14(2):148-54. PubMed ID: 15115616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720.
    Jiang CC; Lai F; Thorne RF; Yang F; Liu H; Hersey P; Zhang XD
    Clin Cancer Res; 2011 Feb; 17(4):721-30. PubMed ID: 21088259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts.
    Pawlak G; Helfman DM
    Mol Biol Cell; 2002 Jan; 13(1):336-47. PubMed ID: 11809843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
    Romerio F; Riva A; Zella D
    Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells.
    Takahashi T; Ueno H; Shibuya M
    Oncogene; 1999 Apr; 18(13):2221-30. PubMed ID: 10327068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
    Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
    Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells.
    Yu XD; Wang SY; Chen GA; Hou CM; Zhao M; Hong JA; Nguyen DM; Schrump DS
    Cancer J; 2007; 13(2):105-13. PubMed ID: 17476138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
    Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
    Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal negative regulation of PDK1 and ASK1 signaling by direct interaction and phosphorylation.
    Seong HA; Jung H; Ichijo H; Ha H
    J Biol Chem; 2010 Jan; 285(4):2397-414. PubMed ID: 19920149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway.
    Birkenkamp KU; Geugien M; Schepers H; Westra J; Lemmink HH; Vellenga E
    Leukemia; 2004 Jan; 18(1):103-12. PubMed ID: 14574326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals.
    von Gise A; Lorenz P; Wellbrock C; Hemmings B; Berberich-Siebelt F; Rapp UR; Troppmair J
    Mol Cell Biol; 2001 Apr; 21(7):2324-36. PubMed ID: 11259582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.
    Saitoh M; Nishitoh H; Fujii M; Takeda K; Tobiume K; Sawada Y; Kawabata M; Miyazono K; Ichijo H
    EMBO J; 1998 May; 17(9):2596-606. PubMed ID: 9564042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras.
    Cristofanelli B; Valentinis B; Soddu S; Rizzo MG; Marchetti A; Bossi G; Morena AR; Dews M; Baserga R; Sacchi A
    Oncogene; 2000 Jul; 19(29):3245-55. PubMed ID: 10918581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
    Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
    Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection of selenite against ischemic brain injury through negatively regulating early activation of ASK1/JNK cascade via activation of PI3K/AKT pathway.
    Wang Q; Zhang QG; Wu DN; Yin XH; Zhang GY
    Acta Pharmacol Sin; 2007 Jan; 28(1):19-27. PubMed ID: 17184578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21(Cip1) downregulation are required for shikonin-induced apoptosis.
    Ahn J; Won M; Choi JH; Kim YS; Jung CR; Im DS; Kyun ML; Lee K; Song KB; Chung KS
    Apoptosis; 2013 Jul; 18(7):870-81. PubMed ID: 23546866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene.
    Agazie Y; Ischenko I; Hayman M
    Oncogene; 2002 Jan; 21(5):697-707. PubMed ID: 11850798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways.
    Penuel E; Martin GS
    Mol Biol Cell; 1999 Jun; 10(6):1693-703. PubMed ID: 10359590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.